UndisclosedDivestiture / carve-outHealthcare & Life SciencesCompleted
424 Capital exits life-sciences engagement firm Reverba
Private equity firm 424 Capital exited Reverba, formerly Health Perspectives Group, which provides patient and healthcare-professional engagement solutions to life sciences companies. Reverba was acquired in a strategic transaction; the buyer and terms were not disclosed.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.
See what you get →